HOME is an global initiative of patients, healthcare professionals, journal editors, regulatory authorities and the pharmaceutical industry. Membership of HOME is open to anyone with an interest in atopic eczema outcomes.
To develop a consensus-based core outcome set (COS) for clinical trials and clinical practice.
HOME Core Outcome Set (for clinical trials)
Clinical signs (Core Outcome Instrument: EASI)
Symptoms (Core Outcome Instrument: POEM)
Long term control
Quality of Life
Wednesday 11 April 2018, 09:00-12:00 (satellite to the ISAD 2018 in Utrecht, The Netherlands). The focus will be on identifying valid and feasible outcome measurement instruments for atopic eczema in routine clinical practice. Contact us to express your interest in attending.
Centre of Evidence Based Dermatology
University of Nottingham
King's Meadow Campus
Lenton Lane, Nottingham
NG7 2NR, UK
Telephone: +44 115 8232435
Fax: +44 115 8468618
Browser does not support script.